Does ERYTHROMYCIN ESTOLATE Cause Therapeutic product effect incomplete? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Therapeutic product effect incomplete have been filed in association with ERYTHROMYCIN ESTOLATE. This represents 59.2% of all adverse event reports for ERYTHROMYCIN ESTOLATE.
58
Reports of Therapeutic product effect incomplete with ERYTHROMYCIN ESTOLATE
59.2%
of all ERYTHROMYCIN ESTOLATE reports
0
Deaths
32
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From ERYTHROMYCIN ESTOLATE?
Of the 58 reports, 32 (55.2%) required hospitalization, and 2 (3.4%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERYTHROMYCIN ESTOLATE. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does ERYTHROMYCIN ESTOLATE Cause?
Drug hypersensitivity (76)
Infection (69)
Drug intolerance (68)
International normalised ratio fluctuation (68)
Nausea (61)
Vomiting (61)
Bloody discharge (60)
Lyme disease (58)
Fatigue (56)
Dizziness (36)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)